Celularity（CELU.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他51.94%
上市公司21.91%
机构投资者13.24%
个人与内部人士12.24%
私营企业0.67%

主要股东

主要股东最新
股东
Genting Berhad	17.78%	514.74 万	0.07%	+0	2025/10/30
Genting Berhad	17.78%	514.74 万	0.07%	+0	2025/10/30
Robert HaririFounder, CEO & Chairman	9.86%	285.36 万	0.05%	-4,463.00	2026/04/13
Robert HaririFounder, CEO & Chairman	9.86%	285.36 万	0.05%	-4,463.00	2026/04/13
Starr International Investments Limited	5.62%	162.81 万	0.02%	+0	2025/10/30
Starr International Investments Limited	5.62%	162.81 万	0.02%	+0	2025/10/30
Bristol-Myers Squibb Company	4.13%	119.53 万	0.02%	+0	2025/02/07
Bristol-Myers Squibb Company	4.13%	119.53 万	0.02%	+0	2025/02/07
C.V. Starr & Co., Inc.	2.64%	76.41 万	<0.01%	+0	2026/03/31
C.V. Starr & Co., Inc.	2.64%	76.41 万	<0.01%	+0	2026/06/30
Vanguard Capital Management, LLC	2.42%	70.10 万	<0.01%	+0	2026/06/30
Vanguard Capital Management, LLC	2.42%	70.10 万	<0.01%	+0	2026/06/30
Peter DiamandisIndependent Director	0.93%	26.92 万	0.07%	+2.04 万	2026/01/12
Peter DiamandisIndependent Director	0.93%	26.92 万	<0.01%	+0	2026/01/12
GX Sponsor LLC	0.66%	19.09 万	<0.01%	+0	2025/02/07
GX Sponsor LLC	0.66%	19.09 万	<0.01%	+0	2025/02/07
Geode Capital Management, LLC	0.58%	16.72 万	0.09%	-2.39 万	2026/06/30
Geode Capital Management, LLC	0.58%	16.72 万	0.09%	-2.39 万	2026/06/30
Geoffrey Shiu LingIndependent Director	0.45%	13.10 万	0.06%	+1.92 万	2026/01/12
Geoffrey Shiu LingIndependent Director	0.45%	13.10 万	<0.01%	+0	2026/01/12